As of January 22, 2025, Organon (OGN) has a market cap of $4.11 billion USD. According to our data, Organon is ranked No.2972 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $4.11 B |
6.94%
|
Dec 31, 2024 | $3.84 B |
9.92%
|
Dec 29, 2023 | $3.50 B |
-45.12%
|
Dec 30, 2022 | $6.37 B |
-4.86%
|
Dec 31, 2021 | $6.70 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
Gilead Sciences
GILD
|
$116.07 B |
0.004 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.38 B |
0.002 M
|
UK
|
Sanofi
SNY
|
$128.55 B |
0.003 M
|
France
|
AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
Teva Pharmaceutical Industries
TEVA
|
$25.08 B |
19.908 M
|
Israel
|
Market Cap | = | OGN Stock Price | * | OGN Shares Outstanding |
= | $15.95 | * | 0.26 B | |
= | $4.11 B |